{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:17:23Z","timestamp":1784380643762,"version":"3.55.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":6452,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Fondo de Investigaciones Sanitarias","award":["FIS\/97\/2073"],"award-info":[{"award-number":["FIS\/97\/2073"]}]},{"DOI":"10.13039\/501100006527","name":"Direcci\u00f3n General de Investigaci\u00f3n Cient\u00edfica y T\u00e9cnica","doi-asserted-by":"crossref","award":["SAF96-0131"],"award-info":[{"award-number":["SAF96-0131"]}],"id":[{"id":"10.13039\/501100006527","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundaci\u00f3 Cl\u00ednic per la Recerca Biom\u00e8dica, the Fondo de Investigaci\u00f3n Sanitaria","award":["96\/1723"],"award-info":[{"award-number":["96\/1723"]}]},{"name":"Hospital Cl\u00ednic i Provincial of Barcelona"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Hepatorenal syndrome is caused by a marked vasoconstriction of the renal circulation. It is suggested that the renal vasoconstriction is related to an overactivity of vasoconstrictor systems secondary to a vasodilation of the arterial circulation that causes a reduction in effective arterial blood volume. To test this hypothesis, 16 cirrhotic patients with hepatorenal syndrome were treated with a combination of ornipressin, a potent vasoconstrictor agent, and plasma volume expansion with albumin to improve effective arterial blood volume. The combined treatment was administered either for 3 or 15 days (8 patients each), and the effects on renal function, vasoactive systems, and systemic hemodynamics were assessed. The 3-day treatment with ornipressin and albumin was associated with a normalization of the overactivity of renin-angiotensin and sympathetic nervous systems, a marked increase in atrial-natriuretic peptide levels, and only a slight improvement in renal function. However, when ornipressin and albumin were administered for 15 days, a remarkable improvement in renal function was observed, with normalization of serum-creatinine concentration, a marked increase in renal plasma flow and glomerular filtration rate, and a persistent suppression in the activity of vasoconstrictor systems. However, 3 of 8 patients on 15-day therapy treatment had to be discontinued because of ischemic complications. In conclusion, the decrease in effective arterial blood volume and the activation of vasoconstrictor systems play a crucial role in the pathogenesis of hepatorenal syndrome. Although the prolonged administration of ornipressin combined with plasma volume expansion reverses hepatorenal syndrome, this treatment should be used with great caution in clinical practice because of the risk of ischemic complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.510270107","type":"journal-article","created":{"date-parts":[[2004,7,27]],"date-time":"2004-07-27T23:42:02Z","timestamp":1090971722000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":255,"title":["Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion"],"prefix":"10.1097","volume":"27","author":[{"given":"M\u00f3nica","family":"Guevara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00f2ria","family":"Fern\u00e1ndez-Esparrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Sort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Manuel","family":"Salmer\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladimiro","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Rod\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1002\/hep.510270107-BIB1|cit1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.1993.105","article-title":"Hepatorenal syndrome","volume":"43","author":"Levy","year":"1993","journal-title":"Kidney Int"},{"key":"10.1002\/hep.510270107-BIB2|cit2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2007-1007294","article-title":"Peripheral arterial vasodilation: Determinant of functional spectrum of cirrhosis","volume":"14","author":"Schrier","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.510270107-BIB3|cit3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/hep.510270107-BIB4|cit4","unstructured":"Epstein M Hepatorenal syndrome. Epstein , M 1996 75 108"},{"key":"10.1002\/hep.510270107-BIB5|cit5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2007-1007201","article-title":"Hepatorenal syndrome","volume":"17","author":"Bataller","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.510270107-BIB6|cit6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-1007299","article-title":"Pathogenesis and management of the hepatorenal syndrome","volume":"14","author":"Laffi","year":"1994","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.510270107-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1002\/hep.510270107-BIB8|cit8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF02146034","article-title":"Vasopressin analogues with selective pressor activity","volume":"2","author":"Berde","year":"1964","journal-title":"Experientia"},{"key":"10.1002\/hep.510270107-BIB9|cit9","first-page":"201","article-title":"Effect of ornithine-8-vasopressin on hemodynamics and diuresis in man","volume":"137","author":"Dun\u00e9r","year":"1971","journal-title":"Acta Chir Scand"},{"key":"10.1002\/hep.510270107-BIB10|cit10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bja\/45.5.511","article-title":"Some cardiovascular effects of ornithine-8-vasopressin: a new surgical vasoconstrictor agent","volume":"45","author":"Coleman","year":"1973","journal-title":"Br J Anaesth"},{"key":"10.1002\/hep.510270107-BIB11|cit11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/hep.1840080333","article-title":"Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction","volume":"8","author":"Gin\u00e8s","year":"1988","journal-title":"Hepatology"},{"key":"10.1002\/hep.510270107-BIB12|cit12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0009-8981(56)90020-1","article-title":"A new method for the determination of inulin in plasma and urine","volume":"1","author":"Heyrovsky","year":"1956","journal-title":"Clin Chim Acta"},{"key":"10.1002\/hep.510270107-BIB13|cit13","first-page":"955","article-title":"A rapid method for the determination of para-aminohippuric acid and kidney function tests","volume":"37","author":"Brun","year":"1951","journal-title":"J Lab Clin Med"},{"key":"10.1002\/hep.510270107-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2214\/ajr.144.6.1283","article-title":"Tongue necrosis after intraarterial vasopressin therapy","volume":"144","author":"Zelch","year":"1985","journal-title":"Am J Roentgenol"},{"key":"10.1002\/hep.510270107-BIB15|cit15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-105-1-96","article-title":"Drug therapy for portal hypertension","volume":"105","author":"Rector","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1002\/hep.510270107-BIB16|cit16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/bja\/73.2.220","article-title":"Dose-response relation of ornipressin with regard to vasoconstriction in human skin","volume":"73","author":"Fruhstorfer","year":"1994","journal-title":"Br J Anaesth"},{"key":"10.1002\/hep.510270107-BIB17|cit17","first-page":"77","article-title":"Multicentric clinical trial of a vasoconstrictor-ornithine vasopressin (POR-8, Sandoz)","volume":"76","author":"Collins","year":"1972","journal-title":"N Z Med J"},{"key":"10.1002\/hep.510270107-BIB18|cit18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/bbrc.1994.2150","article-title":"Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor","volume":"203","author":"Hirasawa","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/hep.510270107-BIB19|cit19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1399-6576.1969.tb00956.x","article-title":"Vasoconstrictors and general anaesthesia","volume":"13","author":"Valentin","year":"1969","journal-title":"Acta Anaesth Scand"},{"key":"10.1002\/hep.510270107-BIB20|cit20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.5694\/j.1326-5377.1971.tb92555.x","article-title":"Cardiovascular effects of ornithine-8-vasopressin (\u201cPOR-8\u201d)","volume":"2","author":"Einstein","year":"1971","journal-title":"Med J Aust"},{"key":"10.1002\/hep.510270107-BIB21|cit21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.30.1.90","article-title":"Beneficial effect of 8-ornithine vasopressin on renal dysfunction in decompensated cirrhosis","volume":"30","author":"Lenz","year":"1989","journal-title":"Gut"},{"key":"10.1002\/hep.510270107-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/0016-5085(91)90734-3","article-title":"Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis","volume":"101","author":"Lenz","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510270107-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1172\/JCI105679","article-title":"Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion","volume":"46","author":"Tristani","year":"1967","journal-title":"J Clin Invest"},{"key":"10.1002\/hep.510270107-BIB24|cit24","first-page":"1175","article-title":"Relationship of systemic and intrarenal hemodynamics in cirrhosis","volume":"89","author":"Epstein","year":"1979","journal-title":"J Lab Clin Med"},{"key":"10.1002\/hep.510270107-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0016-5085(89)91704-6","article-title":"Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure","volume":"97","author":"Fern\u00e1ndez-Seara","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510270107-BIB26|cit26","first-page":"788","article-title":"Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction","volume":"17","author":"Maroto","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/hep.510270107-BIB27|cit27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(84)92115-9","article-title":"Glomerular hyperfiltration after protein ingestion, during glucagon infusion, and in insulin-dependent diabetes is induced by a liver hormone: deficient production of this hormone in hepatic failure causes hepatorenal syndrome","volume":"1","author":"Alvestrand","year":"1984","journal-title":"Lancet"},{"key":"10.1002\/hep.510270107-BIB28|cit28","first-page":"93","article-title":"New clues to the pathophysiology of hepatorenal failure","volume":"71","author":"Lang","year":"1993","journal-title":"Clin Invest Med"},{"key":"10.1002\/hep.510270107-BIB29|cit29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ki.1985.142","article-title":"Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients","volume":"28","author":"Shapiro","year":"1985","journal-title":"Kidney Int"},{"key":"10.1002\/hep.510270107-BIB30|cit30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/hep.1840060213","article-title":"Sodium excretion in advanced cirrhosis: effect of expansion of central volume and suppression of plasma aldosterone","volume":"6","author":"Nicholls","year":"1986","journal-title":"Hepatology"},{"key":"10.1002\/hep.510270107-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/archinte.1977.03630210114033","article-title":"Hepatorenal syndrome: recovery after peritoneovenous shunt","volume":"137","author":"Pladson","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1002\/hep.510270107-BIB32|cit32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ki.1979.8","article-title":"Effects of a portocaval or peritoneovenous shunt on renin in the hepatorenal syndrome","volume":"15","author":"Shroeder","year":"1979","journal-title":"Kidney Int"},{"key":"10.1002\/hep.510270107-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0016-5085(79)90153-7","article-title":"Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion","volume":"77","author":"Wong","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510270107-BIB34|cit34","first-page":"87","volume-title":"The Kidney in Liver Disease","author":"Papper","year":"1983"},{"key":"10.1002\/hep.510270107-BIB35|cit35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510270107-BIB36|cit36","first-page":"1029","volume-title":"Hypertension: pathophysiology, diagnosis and management","volume":"1","author":"Levicki","year":"1995"},{"key":"10.1002\/hep.510270107-BIB37|cit37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/hep.1840200425","article-title":"Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites","volume":"20","author":"Angeli","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/hep.510270107-BIB38|cit38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/physrev.1996.76.2.425","article-title":"Paracrine regulation of the renal microcirculation","volume":"72","author":"Navar","year":"1996","journal-title":"Physiol Rev"},{"key":"10.1002\/hep.510270107-BIB39|cit39","first-page":"F1118","article-title":"De novo intrarenal formation of angiotensin II during control and enhanced renin secretion","volume":"252","author":"Rosivall","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1002\/hep.510270107-BIB40|cit40","first-page":"59","article-title":"Effect of dipyridamole on kidney function in cirrhosis","volume":"17","author":"Llach","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/hep.510270107-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJM199212173272502","article-title":"Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome","volume":"327","author":"Moore","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.510270107-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1172\/JCI114079","article-title":"Glomerular actions of endothelin in vivo","volume":"83","author":"Kon","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1002\/hep.510270107-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(96)91667-0","article-title":"Amelioration of hepatorenal syndrome with selective endothelin-A antagonist","volume":"347","author":"Soper","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/hep.510270107-BIB44|cit44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0016-5085(75)80001-1","article-title":"Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial","volume":"68","author":"Conn","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510270107-BIB45|cit45","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0016-5085(79)90020-9","article-title":"A controlled-comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices","volume":"77","author":"Chojkier","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510270107-BIB46|cit46","doi-asserted-by":"crossref","first-page":"565","DOI":"10.7326\/0003-4819-96-5-565","article-title":"Continuous intravenous vasopressin in active upper gastrointestinal bleeding","volume":"96","author":"Fogel","year":"1982","journal-title":"Ann Intern Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.510270107","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-199801000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:10:38Z","timestamp":1731715838000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-199801000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.510270107","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}